Skip to main content

Vulnerable Pakistanis to get priority for Chinese COVID-19 vaccine


By Masood Sattar Khan
(Pakistan News & Features Services)

China will provide a coronavirus vaccine candidate developed by Sinopharm, a unit of the China National Pharmaceutical Group, to Pakistan as part of a trial agreement.

The University of Karachi and Sinopharm are set to collaborate on vaccine trials and Pakistan will get vaccine doses sufficient to vaccinate one-fifth of its population. 

According to reports, the initial doses will be used to vaccinate the most vulnerable among the Pakistani population including the elderly, healthcare workers and people with medical conditions associated with serious cases of COVID-19.

Earlier in April, Sinopharm had invited the National Institute of Health (NIH), Islamabad, to collaborate in conducting clinical trials of its inactivated vaccine for COVID-19 in Pakistan. 

In a letter sent to NIH Executive Director Maj Gen Dr Aamer Ikram, the general manager of China Sinopharm International Corp, Li Can, had expressed the hope that a successful clinical trial in Pakistan will make it one of the first few countries for the launch of a Covid-19 vaccine. 

The NIH official was then reported to have stated that although clearances were needed for the purpose, the collaboration could be a great thing for Pakistan. Meanwhile, researchers have said that Sinopharm’s coronavirus vaccine candidate appeared to be safe and triggered antibody-based immune responses in early and mid-stage trials. 

The candidate has already moved into a late-stage trial, one of a handful of candidates being tested on several thousand people to see if they are effective enough to win regulatory approval. 

Sinopharm is testing the potential vaccine in the United Arab Emirates (UAE) in a Phase 3 trial expected to recruit 15,000 people, as China has too few new cases to be a useful trial site. 

The shot did not cause any serious side effects, according to a paper published in the Journal of the American Medical Association (JAMA) by scientists who are part of Sinopharm and other China-based disease control authorities and research institutes. The results were based on data from 320 healthy adults in Phase 1 and 2 trials. 

Sinopharm’s chairman told state media last month that a potential vaccine could be ready by the end of this year with Phase 3 testing expected to be completed in about three months. 

The novel coronavirus, which has killed more than 750,000 people globally, has prompted a race to develop a vaccine. More than 150 candidate vaccines are being developed and tested around the world. China is leading the development of at least eight vaccine candidates in different stages of clinical trials.
Labels:

Comments

Post a Comment

Popular posts from this blog

Ambassador explains Chinese role in curbing COVID-19

By Masood Sattar Khan  (Pakistan News & Features Services) The Chinese Ambassador to Pakistan, Yao Jing, attended the preparation and response plan of the new crown epidemic on April 24. According to the details shared by the Chinese Embassy in Islamabad, Ambassador Yao Jing was invited to attend the Pakistan New Crown Outbreak Preparation and Response Plan (PPRP) on video conference. The meeting, organized by the Pakistani Ministry of Foreign Affairs, was also attended by Foreign Minister Shah Mahmood Qureshi, Minister of Economic Affairs, Khasro Bakhtiar, Prime Minister’s Health Adviser Dr Zafar Mirza, Chairman of the National Disaster Management Authority, General Muhammad Afzal, WHO Director-General, Tan Desai besides the representatives of World Bank, United Nations, UNICEF, UNHCR, Asian Development Bank, Islamic Development Bank and envoys from more than 20 countries.  Besides China, envoys from the United States, the United Kingdom, France, Canada, the European Unio...
Post a Comment
Read more

Corona field facility at Karachi Expo Centre may admit patients now

By Mukhtar Alam (Pakistan News & Features Services) The 1,200-bed field isolation centre at the Karachi Expo Centre, on April 6, will open its doors for new COVID-19 infected patients of Karachi and other parts of Sindh who will be referred to it by designated tertiary care hospitals, as the diseases infected another 51 people in six districts of Sindh on April 5.  A source in the provincial health department informed PNFS that authorities have decided not to overburden the designated tertiary care health facilities in terms of corona cases further.  The hospitals have now been asked to admit only new severely ill COVID-19 patients or those seeking intensive cares, while the rest will present at the newly established Expo Centre isolation facility, where the Sindh health department has deployed its doctors, paramedics and other human resources, the source added. Through a letter of the health department, all the district health officers of Karachi division have been asked ...
Post a Comment
Read more

KDSP: Empowering Individuals with Down Syndrome in Karachi

The Karachi Down Syndrome Program (KDSP), a beacon of hope and support, is making significant strides in empowering individuals with Down syndrome in the city. Founded in March 2014 by a group of passionate parents and individuals, KDSP addresses the critical need for comprehensive resources and platforms for those with Down syndrome in Karachi. Bridging the Gap: A Mission of Advocacy and Inclusion KDSP operates as a non-profit organization with a clear mission: to advocate for the value, acceptance, and inclusion of individuals with Down syndrome. Recognizing the limited support and resources available locally, KDSP was established to provide a nurturing environment where individuals with Down syndrome can lead independent and fulfilling lives. A Lifelong Journey of Support Understanding the unique needs of individuals with Down syndrome and their families, KDSP offers unwavering support from the moment a family receives a diagnosis.  They embark on a journey with each family, pro...
Post a Comment
Read more